HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study.

Abstract
A double-blind, placebo-controlled study of mefloquine antimalarial prophylaxis in pregnancy (> 20 weeks of gestation) was conducted in 339 Karen women living in an area of multidrug-resistant malaria transmission on the Thai-Burmese border. Mefloquine gave > or = 86% (95% confidence interval [CI], 59%-94%) protection against Plasmodium falciparum and complete protection against Plasmodium vivax infections. Mefloquine prophylaxis was well tolerated; use of an initial loading dose (10 mg/kg) was associated with transient dizziness, but there were no other significant adverse effects on the mother, the pregnancy, or infant survival or development (followed for 2 years). Falciparum malaria was associated with maternal anemia and a mean reduction in birth weight in gravidae I, II, and III of 225 g (95% CI, 26-423). Maternal anemia at delivery (hematocrit < 30%) was associated with increased infant mortality: 26% versus 15% (relative risk, 1.9; 95% CI, 1.1-3.2). Mefloquine is safe and effective for antimalarial prophylaxis in the second half of pregnancy.
AuthorsF Nosten, F ter Kuile, L Maelankiri, T Chongsuphajaisiddhi, L Nopdonrattakoon, S Tangkitchot, E Boudreau, D Bunnag, N J White
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 169 Issue 3 Pg. 595-603 (Mar 1994) ISSN: 0022-1899 [Print] United States
PMID8158032 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Mefloquine
Topics
  • Adult
  • Anemia (prevention & control)
  • Double-Blind Method
  • Drug Resistance
  • Female
  • Follow-Up Studies
  • Humans
  • Infant, Newborn
  • Malaria (physiopathology, prevention & control)
  • Malaria, Falciparum (prevention & control)
  • Malaria, Vivax (prevention & control)
  • Mefloquine (adverse effects, therapeutic use)
  • Myanmar (epidemiology)
  • Outcome Assessment, Health Care
  • Placenta (parasitology)
  • Pregnancy
  • Pregnancy Complications, Parasitic (prevention & control)
  • Thailand (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: